AxoGen (AXGN) Stock Price, News, Quotes-Moomoo

Account Info

Log Out

US Stock MarketDetailed Quotes

AXGN AxoGen

Watchlist

13.100
+0.200+1.55%

Close Nov 21 16:00 ET

13.350
+0.250+1.91%

Post 16:53 ET

576.51MMarket Cap-39696P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Top 10 Most Expensive Stocks (Only 1 Gets a Quant Sell)
Seeking AlphaNov 17 08:38 ET
Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 9 10:02 ET · Conference Call
Insiders At Axogen Sold US$639k In Stock, Alluding To Potential Weakness
Simply Wall StNov 9 09:35 ET
CCORF Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $17
Moomoo NewsNov 8 09:31 ET · Ratings
Axogen Inc (AXGN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
Yahoo FinanceNov 8 02:08 ET
JMP Securities Maintains AxoGen(AXGN.US) With Buy Rating, Maintains Target Price $20
Moomoo NewsNov 8 01:31 ET · Ratings

Comments

Jsmooth420365

Sep 6 07:55

$AxoGen (AXGN.US)$ like it over 13.50

Cantor Fitzgerald sees AVITA's superior growth and high gross margins as reasons for a premium. The firm also sees potential in Pacific Biosciences and AxoGen, and expects positive share price appreciation for Exagen and NeuroPace. A significant catalyst for Nyxoah's stock is anticipated with upcoming DREAM study data.

Cantor Picks RCEL as Best 2024 Medtech Idea; Bullish on PACB, AXGN, CERS

Moomoo AI

Jan 7 09:21

AxoGen's EBIT loss and debt levels could strain its balance sheet despite its US$368.0m market cap. While revenue is growing, its financial performance is considered slow.

Does AxoGen (NASDAQ:AXGN) Have A Healthy Balance Sheet?

Moomoo AI

Dec 26, 2023 19:36

CEO of Axogen, Karen Zaderej is excited for Kathy Weiler to use her vast commercial knowledge to aid the company's goal of becoming cash flow positive. Weiler herself is equally fired up to be able to aid in Axogen's commercial success.

Press Release: Axogen, Inc. Appoints Kathy Weiler to Its Board of Directors

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

AXGN AxoGen

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target